Bellerophon Therapeutics Price on July 24, 2023
BLPHDelisted Stock | USD 0.71 0.01 1.43% |
If you're considering investing in Bellerophon Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Bellerophon Therapeutics stands at 0.71, as last reported on the 11th of December 2024, with the highest price reaching 0.72 and the lowest price hitting 0.70 during the day. We have found twenty-four technical indicators for Bellerophon Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Bellerophon Therapeutics' Mean Deviation of 5.45, standard deviation of 12.01, and Risk Adjusted Performance of (0.12) to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
Bellerophon Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Bellerophon |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
BLPH |
Based on monthly moving average Bellerophon Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bellerophon Therapeutics by adding Bellerophon Therapeutics to a well-diversified portfolio.
Bellerophon Therapeutics Valuation on July 24, 2023
It is possible to determine the worth of Bellerophon Therapeutics on a given historical date. On July 24, 2023 Bellerophon was worth 0.7 at the beginning of the trading date compared to the closed value of 0.71. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bellerophon Therapeutics pink sheet. Still, in general, we apply an absolute valuation method to find Bellerophon Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bellerophon Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bellerophon Therapeutics' related companies.
Open | High | Low | Close | Volume | |
0.73 | 0.73 | 0.70 | 0.70 | 180,034 | |
07/24/2023 | 0.70 | 0.72 | 0.70 | 0.71 | 48,032 |
0.70 | 0.72 | 0.70 | 0.71 | 0.00 |
Backtest Bellerophon Therapeutics | | | Bellerophon Therapeutics History | | | Bellerophon Therapeutics Valuation | Previous | Next |
Bellerophon Therapeutics Trading Date Momentum on July 24, 2023
On December 11 2024 Bellerophon Therapeutics was traded for 0.71 at the closing time. The top price for the day was 0.72 and the lowest listed price was 0.70 . There was no trading activity during the period 0.0. Lack of trading volume on December 11, 2024 did not affect price variability. The overall trading delta against the current closing price is 1.41% . |
Bellerophon Therapeutics Fundamentals Correlations and Trends
By evaluating Bellerophon Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Bellerophon Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Bellerophon financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Bellerophon Therapeutics Pink Sheet history
Bellerophon Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bellerophon is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bellerophon Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bellerophon Therapeutics stock prices may prove useful in developing a viable investing in Bellerophon Therapeutics
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey. Bellerophon Ther operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 20 people.
Bellerophon Therapeutics Pink Sheet Technical Analysis
Bellerophon Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Bellerophon Therapeutics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Bellerophon Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Bellerophon Therapeutics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Bellerophon Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bellerophon Therapeutics shares will generate the highest return on investment. By undertsting and applying Bellerophon Therapeutics pink sheet market strength indicators, traders can identify Bellerophon Therapeutics entry and exit signals to maximize returns
Bellerophon Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bellerophon Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Bellerophon Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bellerophon to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.12) | |||
Jensen Alpha | (2.43) | |||
Total Risk Alpha | (4.00) | |||
Treynor Ratio | (0.71) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Bellerophon Pink Sheet
If you are still planning to invest in Bellerophon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellerophon Therapeutics' history and understand the potential risks before investing.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |